Lipoprotein from the outer membrane of Escherichia coli was characterized and sequenced by Braun (8) . Its polypeptide chain is composed of 58 amino acids and contains, at the N-terminal end, one amide-linked and two esterlinked fatty acids bound to glycerylcysteine. Over recent years, work in this and other laboratories has established that E. coli lipoprotein is mitogenic, stimulating cultures of murine Blymphocytes into both proliferation and immunoglobulin secretion (1. 5, 13) . These polyclonal responses have been observed with splenic cultures from several strains of mice. including both nude and lipopolysaccharide (LPS) nonresponder strains (5, 6) .
In addition to lipoprotein, LPS (2) and proteins I and I1* (3) are E. coli cell wall components known to possess mitogenic activity in vitro. Although LPS has been shown to induce polyclonal responses in vivo (9, 15 (5) and LPS (7), the basis for this variation is poorly understood.
Earlier studies have shown that LPS, when administered to mice, induces splenomegaly and cellular proliferation (15, 18, 19) . The injection of S. tvphimnurium lipoprotein into BALB/c mice produced similar effects, as the spleens of the lipoprotein-treated mice had, by day 3, almost doubled in weight (Table 1) . This gross morphological change was accompanied by an enhanced recovery of nucleated cells (unpublished results) and is presumably also due to increased lymphocyte proliferation within this organ. In addition to splenomegaly, lipoprotein was found to stimulate the splenic B-lymphocytes into immunoglobulin secretion (Table 1 ). The polyclonal nature of this activation was evident from a 10-fold increase in the number of PFC against TNP-SRBC. The number of PFC against unsensitized SRBC increased about fourfold. The development of this splenic activation was investigated in groups of mice which had been injected intravenously with 35 pg of S. typhimurium lipoprotein 1, 3, 5, or 7 days before assay. The resultant increases in splenic weight (Fig. 2) and PFC numbers (Fig. 3) were similar to those in the previous experiment. Interestingly, both responses developed quickly, peaked on day 3, and then decayed rapidly.
Finally, the in vivo polyclonal B-cell activation induced by S. typhimurium lipoprotein was compared to that induced by E. coli lipoprotein and by E. coli LPS. Separate groups of BALB/c and C3H/HeJ mice were each injected intravenously with 35 ,ug of one of the three mitogens, and their spleens were assayed for the number of PFC against TNP-SRBC. It is apparent that the two preparations of bacterial lipoprotein were able to induce polyclonal responses in both strains of mice, whereas E. coli LPS had such an effect only in BALB/c mice (Table 2) . Recently, a synthetic analog of the N-terminal end of lipoprotein, S-[2,3-bis(palmitoyloxy)-(2RS)-propyl] -N-palmitoyl -(R) -cysteinyl -seryl -serylasparaginyl-alanine (4) was also found to stimulate murine spleen cells in vivo (unpublished observation). These results, like their in vitro counterparts, indicate that any contribution by LPS to the activity of lipoprotein must only be minimal.
Throughout these experiments, lipoprotein prepared from S. typhimurium had an activity comparable to that of lipoprotein prepared from E. coli, suggesting that the mitogenic moiety may be conserved amongst the Enterobacteriaceae. From the practical point of view, S. typhimurium SL761 has proved to be a particularly useful source of lipoprotein. First, this temperature-sensitive mutant is unable to synthesize the entire LPS molecule when grown at 42°C (12) . Second, the yield of lipoprotein is consistently greater than that obtained with E. coli (unpublished observation). Time after injection (days) b The spleen cells within each group were pooled, and the average number of direct PFC against TNP-SRBC ± standard error was determined from quadruplicate assays.
In conclusion, these studies have shown that S. typhimutriimn lipoprotein is also able to polyclonally activate murine B-lymphocytes and that its effects in vivo complement those observed in vitro. They also suggest that these potent bacterial mitogens may have a significant influence on the host-parasite relationship, particularly before the establishment of specific humoral and cellular immune responses. A rapid elevation in the level of serum immunoglobulin, found when specific-pathogen-free mice are exposed to S. typhimm-iirm organisms (10) , supports this hypothesis. Hence, during the initial phase of a bacterial infection, some "protective" antibody, generated as a result of these polyclonal B cell responses, may contribute to host resistance.
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